Artificially low HbA1c associated with treatment with ribavirin
AUTOR(ES)
Robertson, Michael
FONTE
BMJ Publishing Group Ltd.
RESUMO
Ribavirin treatment for hepatitis C may artificially lower HbA1c and give misleading information about glycaemic control
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2258396Documentos Relacionados
- Correlação entre MCP-1, HbA1c e a filtração glomerular em pacientes não diabéticos
- Variation in the Frequency of Hemoglobin A1c (HbA1c) Testing: Population Studies Used to Assess Compliance with Clinical Practice Guidelines and Use of HbA1c to Screen for Diabetes
- Glycemic control in minks with tendency to obesity in the perinatal period with the use of HbA1C
- Third trimester HbA1c and the association with large-for-gestational-age neonates in women with gestational diabetes
- Determinação de HbA1c por CLAE: interferência de variantes de hemoglobinas S e C e alta concentração de HbF